Drooling

Journal of Oral Pathology and Medicine

Volumn 38, Issue 4, 2009, Pages 321-327

  Scully, Crispian ^a   Limeres, Jacobo ^b,d   Gleeson, Michael ^c   Tomás, Inmaculada ^b   Diz, Pedro ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Drooling; Oral health; Saliva; Sialorrhea

Indexed keywords

ATROPINE; BENZATROPINE; BOTULINUM TOXIN A; CLONIDINE; CLOZAPINE; GLYCOPYRRONIUM BROMIDE; IPRATROPIUM BROMIDE; SCOPOLAMINE; TRIHEXYPHENIDYL;

BEHAVIOR CHANGE; BEHAVIOR THERAPY; BLURRED VISION; CAROTID ARTERY INJURY; CEREBRAL PALSY; CHRONIC DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONSTIPATION; DISEASE SEVERITY; DIZZINESS; DOWN SYNDROME; DRUG DOSE TITRATION; DRUG ERUPTION; DRUG INDUCED DISEASE; DYSPHAGIA; FACIAL NERVE INJURY; FACIAL NERVE PARALYSIS; FAMILY; FUNCTIONAL TRAINING; GLAUCOMA; HEMATOMA; HUMAN; HYPERACTIVITY; HYPERSALIVATION; INFECTION; INJECTION PAIN; IRRITABILITY; JAW MALFORMATION; LASER COAGULATION; LEARNING DISORDER; MUSCLE WEAKNESS; NEURECTOMY; PARKINSON DISEASE; PAROTID DUCT LIGATION; PAROTID DUCT REROUTING; PATHOPHYSIOLOGY; PHYSIOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SALIVARY GLAND DISEASE; SALIVATION; SIDE EFFECT; SINGLE DRUG DOSE; SPEECH THERAPY; SUBMANDIBULAR DUCT REROUTING; SUBMANDIBULAR GLAND EXCISION; SURGICAL TECHNIQUE; SWALLOWING; THERAPY EFFECT; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; URINE RETENTION;

HUMANS; MUSCARINIC ANTAGONISTS; NERVOUS SYSTEM DISEASES; NEUROMUSCULAR AGENTS; PHYSICAL THERAPY MODALITIES; SALIVARY GLANDS; SIALORRHEA;

EID: 62949150476     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00727.x     Document Type: Review

References (64)

1. Blasco PA, Allaire JH, and participants of the Consortium on Drooling. Drooling in the developmentally disabled: management practices and recommendations. Dev Med Child Neurol 1992 34 : 849 62.
2. Crysdale WS. Management options for the drooling patient. Ear Nose Throat J 1989 68 : 820, 825-6, 829-30.
3. Sreebny LM. Saliva in health and disease: an appraisal and update. Int Dent J 2000 50 : 140 61.
4. Tahmassebi JF, Curzon ME. The cause of drooling in children with cerebral palsy - hypersalivation or swallowing defect. Int J Paediatr Dent 2003 13 : 106 11.
5. Pedersen AM, Bardow A, Jensen SB, Nauntofte B. Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral Dis 2002 8 : 117 29.
6. Garrett JR, Proctor GB. Control of salivation. In : Linden RWA ed. The Scientific Basis of Eating. Ront Oral Biol. Basel : Karger, 1998 135 55.
7. Hockstein NG, Samadi DS, Gendron K, Handler SD. Sialorrhea: a management challenge. Am Fam Physician 2004 69 : 2628 34.
8. Dodds WJ. Physiology of swallowing. Dysphagia 1989 3 : 171 8.
9. Hamdy S, Aziz Q, Rothwell JC, Hobson A, Barlow J, Thompson DG. Cranial nerve modulation of human cortical swallowing motor pathways. Am J Physiol 1997 1272 : 802 8.
10. Hamdy S, Aziz Q, Rothwell JC, et al. The cortical topography of human swallowing musculature in health and disease. Nature Med 1996 2 : 1217 24.
11. Zoungrana OR, Amri M, Car A, Roman C. Intracellular activity of motoneurons of the rostral nucleus ambiguous during swallowing in sheep. J Neurophysiol 1997 77 : 909 22.
12. Jenkins GN. Saliva. In : Jenkins GN ed. The Physiology and Biochemistry of the Mouth, 4th edn. Oxford : Blackwell Scientific Publications, 1978 284 359.
13. Nunn JH. Drooling: Review of the literature and proposals for management. J Oral Rehabil 2000 27 : 735 43.
14. Myer C. Sialorrhea. Pediatr Clin North Am 1989 36 : 1495 500.
15. Lespargot A, Langevin MF, Muller S, Guillemont S. Swallowing disturbances associated with drooling in cerebral-palsied children. Dev Med Child Neurol 1993 35 : 298 304.
16. Johnson H, Scott A. A Practical Approach to Saliva Control. Tucson, AZ : Communication Skill Builders Inc., 1993.
17. Harris SR, Purdy AH. Drooling and its management in cerebral palsy. Dev Med Child Neurol 1987 29 : 807 11.
18. Limbrock GJ, Hoyer H, Scheyling H. Regulation therapy by Castillo-Morales in children with Down's syndrome: primary and secondary orofacial pathology. ASDC J Dent Child 1990 57 : 437 41.
19. Crysdale WS, White A. Submandibular duct relocation for drooling: A 10-year experience with 194 patients. Otolaryngol Head Neck Surg 1989 101 : 87 92.
20. Limbrock GJ, Hoyer H, Scheying H. Drooling, chewing and swallowing dysfunctions in children with cerebral palsy: treatment according to Castillo-Morales. ASDC J Dent Child 1990 57 : 445 51.
21. Volonte MA, Porta M, Comi G. Clinical assessment of dysphagia in early phases of Parkinson's disease. Neurol Sci 2002 23 (Suppl. 2 S121 2.
22. Sullivan PB, Lambert B, Rose M, Ford-Adams M, Johnson A, Griffiths P. Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford Feeding Study. Dev Med Child Neurol 2000 42 : 674 80.
23. Boyce HW, Bakheet MR. Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease. J Clin Gastroenterol 2005 39 : 89 97.
24. Donald PJ. Surgical rehabilitation following anterior resection for oral cavity carcinoma. Laryngoscope 1981 91 : 1941 56.
25. Reddihough D, Johnson H, Ferguson E. The role of a saliva control clinic in the management of drooling. J Paediatr Child Health 1992 28 : 395 7.
26. Fischer-Brandies H, Avalle C, Limbrock GJ. Therapy of orofacial dysfunctions in cerebral palsy according to Castillo-Morales: first results of a new treatment concept. Eur J Orthod 1987 9 : 139 43.
27. Wilkie TF, Brody GS. The surgical treatment of drooling. A ten-year review. Plast Recontr Surg 1977 59 : 791 8.
28. Jongerius PH, Rotteveel JJ, Van Limbeek J, Gabreels FJ, Van Hulst K, Van Den Hoogen FJ. Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology 2004 63 : 1371 5.
29. Limbrock GJ, Fischer-Brandies H, Avalle C. Castillo-Morales' orofacial therapy: treatment of 67 children with Down syndrome. Dev Med Child Neurol 1991 33 : 296 303.
30. Blasco PA. Management of drooling: 10 years after the Consortium on Drooling, 1990. Dev Med Child Neurol 2002 44 : 778 81.
31. Crysdale WS, Mccann C, Roske L, Joseph M, Semenuk D, Chait P. Saliva control issues in the neurologically challenged. A 30 year experience in team management. Int J Pediatr Otorhinolaryngol 2006 70 : 519 27.
32. Meningaud JP, Pitak-Arnnop P, Chikhani Lbertrand JC. Drooling of saliva: a review of the etiology and management options. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 101 : 48 57.
33. Johnson HM, Reid SM, Hazard CJ, Lucas JO, Desai M, Reddihough DS. Effectiveness of the Innsbruck Sensorimotor Activator and Regulator in improving saliva control in children with cerebral palsy. Dev Med Child Neurol 2004 46 : 39 45.
34. Haberfellner H. ISMAR: an autotherapeutic device assisting patients from drooling to articulated speech. Pediatr Rehabil 2005 8 : 248 62.
35. Inga CJ, Reddy AK, Richardson SA, Sanders B. Appliance for chronic drooling in cerebral palsy patients. Pediatr Dent 2001 23 : 241 2.
36. Mccracken A. Drool control and tongue thrust therapy for the mentally retarded. Am J Occup Ther 1978 32 : 79 85.
37. Domaracki LS, Sisson LA. Decreasing drooling with oral motor stimulation in children with multiple disabilities. Am J Occup Ther 1990 44 : 680 4.
38. Koheil R, Sochaniwskyj AE, Bablich K, Kenny DJ, Milner M. Biofeedback techniques and behaviour modification in the conservative remediation of drooling by children with cerebral palsy. Dev Med Child Neurol 1987 29 : 19 26.
39. Harris MM, Dignam PF. A non-surgical method of reducing drooling in cerebral palsied children. Dev Med Child Neurol 1980 22 : 293 9.
40. Lancioni GE, Brouwer JA, Coninx F. Automatic cueing to reduce drooling: a long-term follow-up with two mentally handicapped persons. J Behav Ther Exp Psychiatry 1994 25 : 149 52.
41. Van Der Burg JJ, Didden R, Jongerius PH, Rotteveel JJ. A descriptive analysis on behavioural treatment of drooling (1970-2005). Dev Med Child Neurol 2007 49 : 390 4.
42. Jongerius PH, Van Tiel P, Van Limbeek J, Gabreels FJ, Rotteveel JJ. A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling. Arch Dis Child 2003 88 : 911 4.
43. Dworkin J, Nadal J. Nonsurgical treatment of drooling in a patient with closed head injury and severe dysarthria. Dysphagia 1991 6 : 40 9.
44. De Simone GG, Eisenchlas JH, Junin M, Pereyra F, Brizuela R. Atropine drops for drooling: a randomized controlled trial. Palliat Med 2006 20 : 665 71.
45. Talmi YP, Finkelstein Y, Zohar Y. Reduction of salivary flow with transdermal scopolamine: a four-year experience. Otolaryngol Head Neck Surg 1990 103 : 615 8.
46. Lewis DW, Fontana C, Mehallick LK, Everett Y. Transdermal scopolamine for reduction of drooling in developmentally delayed children. Dev Med Child Neurol 1994 36 : 484 6.
47. Zeppetella G. Nebulized scopolamine in the management of oral dribbling: three case reports. J Pain Symptom Manage 1999 17 : 293 5.
48. Owen SE, Stern ML. Management of drooling in cerebral palsy: three single case studies. Int J Rehabil Res 1992 15 : 166 9.
49. Camp-Bruno JA, Winsberg BG, Green-Parsons AR, Abrams JP. Efficacy of benztropine therapy for drooling. Dev Med Child Neurol 1989 31 : 309 19.
50. Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M. Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study. Arch Pediatr Adolesc Med 2000 154 : 1214 8.
51. Blasco PA, Stansbury JC. Glycopyrrolate treatment of chronic drooling. Arch Pediatr Adolesc Med 1996 150 : 932 5.
52. Grabowski J. Clonidine treatment of clozapine-induced hypersalivation. J Clin Psychopharmacol 1992 12 : 69 70.
53. Benson J, Daugherty KK. Botulinum toxin A in the treatment of sialorrhea. Ann Pharmacother 2007 41 : 79 85.
54. Nobrega AC, Rodrigues B, Torre AC, Enzo A, Melo A. Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson′s disease? J Neurol Sci 2007 253 : 85 7.
55. Fuster Torres MA, Berini Aytés L, Gay Escoda C. Salivary gland application of botulinum toxin for the treatment of sialorrhea. Med Oral Patol Oral Cir Bucal 2007 12 : 511 7.
56. Mancini F, Zangaglia R, Cristina S, et al. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord 2003 18 : 685 8.
57. Postma AG, Heesters M, Van Laar T. Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism. Mov Disord 2007 22 : 2430 5.
58. Stalpers LJ, Moser EC. Results of radiotherapy for drooling in amyotrophic lateral sclerosis. Neurology 2002 58 : 1308.
59. Andersen PM, Gronberg H, Franzen L, Funegard U. External radiation of the parotid glands significantly reduces drooling in patients with motor neurone disease with bulbar paresis. J Neurol Sci 2001 191 : 111 4.
60. Neppelberg E, Haugen DF, Thorsen L, Tysnes OB. Radiotherapy reduces sialorrhea in amyotrophic lateral sclerosis. Eur J Neurol 2007 14 : 1373 7.
61. Burton MJ. The surgical management of drooling. Dev Med Child Neurol 1991 33 : 1110 6.
62. Chilla R, Nicklatsch J, Arglebe C. Late sequelae of iatrogenic damage to chorda tympani nerve. Acta Otolaryngol 1982 94 : 461 5.
63. Glynn F, Dwyer TP. Does the addition of sublingual gland excision to submandibular duct relocation give better overall results in drooling control? Clin Otolaryngol 2007 32 : 103 7.
64. Martin TJ, Conley SF. Long-term efficacy of intra-oral surgery for sialorrhea. Otolaryngol Head Neck Surg 2007 137 : 54 8.